On June 12, 2026, South Korea’s Ministry of Food and Drug Safety (MFDS) revised the implementation rules for ZLD system certification, adding a mandatory full-process TOC traceability verification requirement for pharmaceutical and biomanufacturing water systems seeking certification. For exporters, system integrators, laboratories, and buyers involved in ZLD projects for the Korean market, this matters because certification will now depend not only on system design and operation, but also on traceable analytical evidence accepted through KOLAS-recognized testing.

According to the information provided, MFDS issued the 2026 revised version of the detailed rules for ZLD system certification on June 12, 2026. The revision introduces a compulsory TOC (total organic carbon) end-to-end traceability verification requirement.
For all pharmaceutical and biomanufacturing water systems applying for ZLD certification, a KOLAS-recognized laboratory must conduct TOC isotopic fingerprint comparison across four points: influent water, intermediate water, reused water, and concentrated water. A traceability analysis report must also be submitted as part of the certification process.
The new requirement will take effect on September 1, 2026. The information provided also indicates that Chinese ZLD equipment exporters need to engage with KOLAS-recognized laboratories in advance.
Analysis shows that exporters serving the South Korean pharmaceutical and biomanufacturing market may be affected first, because certification readiness now includes laboratory traceability arrangements in addition to equipment delivery. The impact is likely to be felt in pre-sales preparation, project documentation, and certification support provided to customers.
What deserves closer attention is whether exporters can align project timelines with KOLAS laboratory workflows before the September 1, 2026 implementation date.
From an industry perspective, buyers and project owners pursuing ZLD certification in South Korea may need to assess testing and report preparation earlier in the procurement cycle. The rule points to a process in which analytical verification becomes part of certification planning rather than a late-stage formality.
The main area to watch is how the four required sampling nodes are reflected in project execution, acceptance planning, and communication with equipment suppliers and laboratories.
Observably, laboratories and compliance support providers may take on a more central role because the new requirement specifically calls for KOLAS-recognized testing and a traceability analysis report. Their involvement is likely to affect scheduling, sample management, and the completeness of certification files.
For service providers, the key change is not only technical testing, but also how testing outputs are integrated into certification submission packages.
Analysis shows that companies should closely follow any additional MFDS clarifications tied to the revised certification rules. The current signal is clear on the need for TOC traceability verification, but actual implementation often depends on how testing scope, reporting expectations, and submission practice are interpreted in the market.
For exporters and project teams, an immediate practical focus is whether a KOLAS-recognized laboratory can be engaged early enough to support sampling, comparison, and report issuance. This is especially relevant for companies already negotiating projects that may move into certification after September 1, 2026.
What deserves closer attention is the difference between a policy requirement and on-site execution. Even where system hardware is ready, certification progress may still depend on whether sampling, isotopic fingerprint comparison, and traceability reporting can be completed within the project schedule. This makes delivery planning and customer communication more sensitive than before.
Companies supporting Korean-market ZLD projects should also review how they present compliance materials to customers. The new rule suggests that supporting documents linked to influent water, intermediate water, reused water, and concentrated water may become more important in technical discussions and certification preparation.
Observably, this development is better understood as a concrete compliance tightening rather than a purely formal update. The revised rule does not simply reference TOC as a parameter; it introduces a traceability framework tied to four process nodes and to KOLAS-recognized laboratory verification.
At the same time, it is more appropriate to understand this as an implementation-stage signal rather than a completed market outcome. The rule is confirmed, and the effective date is stated, but the full operational impact on project cycles, customer requirements, and exporter response still needs to be watched after the September 2026 start date.
From an industry perspective, the immediate meaning of this update is that ZLD certification for pharmaceutical and biomanufacturing water systems in South Korea is becoming more evidence-driven at the testing and reporting level. The change should not be overstated as a broad market reset, but it does raise the compliance threshold for companies participating in certification-related projects.
At this stage, it is more appropriate to understand the news as a near-term operational change with possible longer-term signaling value. The operational change is clear because the effective date and core requirement are already defined. The longer-term significance will depend on how consistently the new traceability requirement is enforced in practice.
This article is generated based on the user-provided news title, event date, and event summary. The confirmed facts in the article are limited to the provided information about the MFDS revision, the mandatory TOC traceability verification requirement, the role of KOLAS-recognized laboratories, the four required sampling points, the need for a traceability analysis report, and the September 1, 2026 effective date.
For this type of development, commonly relevant source categories may include official regulatory notices, company announcements, industry association updates, authoritative media reporting, and standards-related documents. No specific official source link was provided in the input, so the exact official link remains to be continuously verified. Follow-up attention should focus on any additional MFDS clarification and on how the new requirement is applied in actual certification submissions.
Get weekly intelligence in your inbox.
No noise. No sponsored content. Pure intelligence.